Canadian courts have approved a $17.6 million settlement in a class-action lawsuit launched by individuals who became diabetic after taking an antipsychotic drug.
The settlement with Eli Lilly, manufacturer of Zyprexa, was announced Wednesday. It stems from allegations that the drug giant failed to warn about risks of severe weight gain, diabetes, hyperglycemia and pancreatitis.
1 comment:
Zyprexa has generated a lot of bad press,criminal charge and fines for Eli Lilly and they still have unresolved Zyprexa settlement claims in the USA.
Zyprexa caused death and damage for many patients myself included.-Daniel Haszard Zyprexa whistle-blower
Post a Comment